Impact of Cardiac Comorbidity on Early Outcomes after Pancreatic Resection
In patients undergoing pancreatic resection (PR), identification of subgroups at increased risk for postoperative complications can allow focused interventions that may improve outcomes.
Patients undergoing PR from 2005–2010 were selected from the American College of Surgeons National Surgical Quality Improvement Program database and categorized as having any history of cardiac disease (angina, congestive heart failure (CHF), myocardial infarction (MI), cardiac stent, or bypass) or as having acute cardiac disease (symptoms of CHF or angina within 30 days or MI within 6 months). These variables were utilized to examine the relationship between cardiac disease and outcomes after PR.
The rate of serious complications and perioperative mortality in patients with any history of cardiac disease vs. those without was 34 vs. 24 % (p < 0.001) and 4.5 vs. 2.0 % (p < 0.001), respectively, and in patients with acute cardiac disease compared to patients without was 37 vs. 25 % (p < 0.001) and 8.6 vs. 2.2 % (p < 0.001), respectively. In multivariate analysis, the two cardiac disease variables remained associated with mortality.
In patients undergoing PR, cardiac disease is a significant risk factor for adverse outcomes. These observations are critical for meaningful informed consent in patients considering pancreatectomy.
KeywordsPancreatic resection Pancreatic surgery Cardiac disease American College of Surgeons National Surgical Quality Improvement Program Surgical outcomes
- 1.van Heek, N. T., Kuhlmann, K. F., Scholten, R. J., de Castro, S. M., Busch, O. R., van Gulik, T. M., Obertop, H., Gouma, D. J. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005; 242(6): 781–90.PubMedCrossRefGoogle Scholar
- 4.Sohn, T. A., Yeo, C. J., Cameron, J. L., Koniaris, L., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., Lillemoe, K. D. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4(6): 567–79.PubMedCrossRefGoogle Scholar
- 5.Kuhlmann, K. F., de Castro, S. M., Wesseling, J. G., ten Kate, F. J., Offerhaus, G. J., Busch, O. R., van Gulik, T. M., Obertop, H, Gouma, D. J. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004; 40(4): 549–58.PubMedCrossRefGoogle Scholar
- 9.Yeo, C. J., Cameron, J. L., Lillemoe, K. D., Sauter, P. K., Coleman, J., Sohn, T. A., Campbell, K. A., Choti, M. A. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000; 232(3): 419–29.PubMedCrossRefGoogle Scholar
- 10.Kennedy, T.J., Cassera, M.A., Wolf, R.,Swanstrom, L. L., Hansen, P. D. Surgeon volume versus morbidity and cost in patients undergoing pancreaticoduodenectomy in an academic community medical center. J Gastrointest Surg; 14(12): 1990–6.Google Scholar
- 17.ACSNSQIP. American College of Surgeons National Surgical Quality Improvement Program. 2013; Available from: http://site.acsnsqip.org/. Accessed 2013 March 13.
- 20.DeOliveira, M.L., Winter, J.M., Schafer, M., Cunningham, S. C., Cameron, J. L., Yeo, C. J., Clavien, P. A.. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006; 244(6): 931–9.PubMedCrossRefGoogle Scholar
- 25.Wente, M. N., Bassi, C., Dervenis, C., Fingerhut, A., Gouma, D. J., Izbicki, J. R., Neoptolemos, J. P., Padbury, R. T., Sarr, M. G., Traverso, M. W., Yeo, C. J., Buchler, M. W. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142(5): 761–8.PubMedCrossRefGoogle Scholar